Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 21, 2017
Pharmacy Choice - News - U.S. Pharmaceutical Industry - November 21, 2017

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

11/21/17 - Agency to crack down on stem cell offerings
WASHINGTON U.S. health authorities announced plans Thursday to crack down on doctors pushing stem cell procedures that pose the gravest risks to patients amid an effort to police a burgeoning medical field that previously has received little oversight. FDA officials said they will focus their enforcement efforts on bad actors who inject st
11/21/17 - Auto-Injectors Market Expected to Witness a Sustainable Growth over 2016 - 2026: The market is anticipated to exhibit a CAGR of 15.1% during the forecast period and is projected to be valued at nearly US$ 7,000 Mn by the end of 2026.
Valley Cottage, NY 11/20/2017 Improving healthcare infrastructure across several countries and regions, coupled with availability of well-developed manufacturing units, facilitates the growth of medical device businesses. In the report, titled "Auto-Injectors Market: Global Industry Analysis and Opportunity Assessment, 2016-2026," nearly...
11/21/17 - Companion Animal Vaccines Market to Register a Stout Growth by 2026 End: According to Future Market Insights research, lack of information on emerging virulent veterinary diseases, and decline sales revenues through veterinarians can stifle demand
Valley Cottage, NY 11/20/2017 Zoetis Inc. will continue to account for a leading share of the US$ 2.26 Bn global companion animal vaccine market. The pharmaceutical company accounted for over 46% share of the global market in 2015, and it is expected to maintain its numero uno position during the forecast period 2016-2026. Merck& Co., Inc. an
11/21/17 - Determination That TRINTELLIX (Vortioxetine Hydrobromide) Oral Tablet, EQ 15 Milligram Base, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
FDA -2017- P-3989, FDA -2017- P-4195, FDA -2017- P-5114, FDA -2017- P-5909, FDA -2017- P-5910, and FDA -2017- P-5967 ". This determination will allow FDA to approve abbreviated new drug applications for vortioxetine hydrobromide oral tablet, 15 mg base, if all other legal and regulatory requirements are met. Under FDA regulations, drugs are removed
11/21/17 - Drug Discovery Services Market Worth 14.40 Billion USD by 2022: The drug discovery services market is expected to reach USD 14.40 Billion by 2022 from USD 8.32 Billion in 2017, at a CAGR of 11.6%.
Seattle, WA 11/20/2017 The report "Drug Discovery Services Market by Process, Type, Drug Type, Therapeutic Areas- Forecast to 2022", The drug discovery services market is expected to reach USD 14.40 Billion by 2022 from USD 8.32 Billion in 2017, at a CAGR of 11.6%. The major factors driving the growth of this market are increasing research an
11/21/17 - FDA OKs new therapy for some hemophilia patients
The list price will be about $482,000 for the first year and slightly less after that, said California- based Genentech, which developed the drug. Genentech, the biotech subsidiary of Swiss drugmaker Roche, said that is half the cost of the only other preventive option for patients with this problem. The FDA gave expedited approval to Hemlibra, als
11/21/17 - Home Infusion Therapy Market Is Poised to Reach US$ 26,747.8 Mn in Terms of Revenue by 2020: In cases of gastrointestinal diseases, diabetes and cancer-related pain infusion therapy is common. Moreover, infusion therapy is equally effective in treati
Albany, NY 11/20/2017 According to a new market report published by Persistence Market Research "Global Market Study on Home Infusion Therapy Devices- Needleless Connectors to Witness Highest Growth by 2020", the global home infusion therapy devices market was valued at US$ 15,905.1 Mn in 2014 and is expected to grow at a CAGR of 9% from 2014
11/21/17 - Investigators at University of Illinois Detail Findings in Veterinary Microbiology (The viral innate immune antagonism and an alternative vaccine...
By a News Reporter-Staff News Editor at Life Science Weekly Researchers detail new data in Veterinary Medicine- Veterinary Microbiology. Funders for this research include US Department of Agriculture, National Institute of Food and Agriculture, USDA HATCH and Multistate Funds. The news reporters obtained a quote from the research from the Univers
11/21/17 - Kalo auto-injector for infants approved Kaleo auto-injector for infants approved
Richmond-based pharmaceutical company Kalo has received federal approval to market an epinephrine auto-injector to treat life-threatening allergic reactions in babies as small as 16.5 pounds. The U.S. Food and Drug Administration on Friday tweeted approval for a new dosage of Kalo's Auvi-Q epinephrine device. Vivian Hernandez-Trujillo, a Miami-
11/21/17 - Next Generation Antibody Therapeutics Market to Witness a Rise of US $6,761.1 Mn Through 2015-2022: Massive success of the discovery and development of monoclonal antibodies initially provided a strong impetus to the development of next-generation an
Albany, NY 11/20/2017 According to a new market report published by Persistence Market Research "Global Market Study on Next-Generation Antibody Therapeutics: Biosimilar Antibody Products to Witness Highest Growth by 2022", the global next-generation antibody therapeutics market is project to be valued at US$ 2,250.0 Mn by the end of 2015 and
11/21/17 - Patent Issued for Composition of Tiacumicin Compounds (USPTO 9808530)
By a News Reporter-Staff News Editor at Life Science Weekly A patent by the inventors Murakami, Yoshiyuki; Saito, Hikaru, filed on January 14, 2014, was published online on November 7, 2017, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 9808530 is assigned to Astellas Pharma Europe Ltd.
11/21/17 - Report Summarizes Drug Delivery Systems Study Findings from Department of Biomedical Engineering (Vessel-Targeted Chemophototherapy with Cationic...
Report Summarizes Drug Delivery Systems Study Findings from Department of Biomedical Engineering. By a News Reporter-Staff News Editor at Cancer Weekly Researchers detail new data in Drugs and Therapies- Drug Delivery Systems. Our news journalists obtained a quote from the research from the Department of Biomedical Engineering, "Near-infrared lig
11/21/17 - Technology, retail send stocks higher
NEW YORK- U.S. stocks rose Monday as a mix of smaller, U.S.- focused companies, technology firms and banks climbed. Merck fell after a good report from competitor Roche about a drug that competes with Merck' s cancer medication Keytruda. That's probably going to be the case throughout the week as the Thanksgiving holiday approaches and investors tu
11/21/17 - UGA, Sanofi Pasteur develop new broadly protective vaccines for H3N2 influenza
By a News Reporter-Staff News Editor at Life Science Weekly Athens, Ga.- A collaborative research and development partnership between researchers at the University of Georgia and Sanofi Pasteur, the largest influenza vaccine manufacturer in the world, has resulted in the identification of a vaccine candidate that protects against multiple...
11/20/17 - "Composition and Method for Treatment of Depression and Psychosis in Humans" in Patent Application Approval Process (USPTO 20170312275)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventor Javitt, Daniel C., filed on July 16, 2017, was made available online on November 9, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Glytech LLC. "Diagnosis of schi
11/20/17 - "Dual-Chamber Pack for Pharmaceutical Compositions" in Patent Application Approval Process (USPTO 20170312177)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors BHARGAVA, Rahul; MITTAL, Bhupesh Kumar, filed on May 2, 2016, was made available online on November 9, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a
11/20/17 - "Low Dose Pharmaceutical Composition" in Patent Application Approval Process (USPTO 20170312254)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors MALHOTRA, Geena; PURANDARE, Shrinivas Madhukar, filed on July 14, 2017, was made available online on November 9, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assi
11/20/17 - "Mission: Cure" Launched to Harness Innovative Financing and Impact Investing to Cure Disease; Pioneers New Approach by Attacking Pancreatic Disease
By a News Reporter-Staff News Editor at Clinical Trials Week The new nonprofit Mission: Cure will convene the world's leading pancreatic experts at the American Pancreatic Association meeting in San Diego on November 10th to devise a 10- year plan to cure chronic pancreatitis, a painful and costly pancreatic disease, using an innovative financing
11/20/17 - "Pharmaceutical Composition and Use Thereof" in Patent Application Approval Process (USPTO 20170312234)
By a News Reporter-Staff News Editor at Clinical Trials Week A patent application by the inventor Lin, Jung-Yaw, filed on May 2, 2016, was made available online on November 9, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to National Taiwan Normal University.
11/20/17 - "Pyrazolo[1,5-A]pyridine Compounds and Use Thereof" in Patent Application Approval Process (USPTO 20170313697)
By a News Reporter-Staff News Editor at Clinical Trials Week A patent application by the inventors Lu, Xiaoyun; Tang, Jian; Ding, Ke; Zhang, Tianyu; Zhang, Xiantao; Tu, Zhengchao; Wu, Tian; Wan, Junting; Cao, Yuanyuan; He, Shengjiang, filed on August 13, 2015, was made available online on November 9, 2017, according to news reporting originating
11/20/17 - 'It never really leaves you.' Opioids haunt users' recovery
Addiction to powerful painkillers has ensnared millions of Americans, and created the worst drug epidemic in U.S. history. Now many share a daily struggle for recovery, a battle fraught with ironies, tragedies and sometimes shaky success. Survival means rejecting cravings for a high, often with the help of anti-addiction medicine similar to pills t
11/20/17 - Acadia Pharmaceuticals Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (Nov. 7, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acadia Pharmaceuticals Inc. was posted on November 7, 2017. The SEC file number is 0001564590-17-022271.. A U.S. Securities and Exchange Commission f
11/20/17 - Acadia Pharmaceuticals Inc. Files SEC Form 8-K, Current Report: (Nov. 7, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acadia Pharmaceuticals Inc. was posted on November 7, 2017. The SEC file number is 0001415889-17-001754.. A U.S. Securities and Exchange Commission f
11/20/17 - Acasti Pharma Announces Development and Commercialization Discussions Progressing with a Leading China Pharmaceutical Partner
Acasti Pharma Inc., a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre for the treatment of severe hypertriglyceridemia, today announced that the company recently entered into a non-binding term sheet with a leading China- based pharmaceutical company.
11/20/17 - Acceleron Announces Appointment of Dr. Karen Smith to its Board of Directors and Departure of Terrance McGuire
CAMBRIDGE, Mass.- Acceleron Pharma Inc. today announced the appointment of the experienced biopharmaceutical executive, Karen Smith, M.D., Ph.D., to its board of directors and the departure of Terrance McGuire, effective November 15, 2017. Dr. Smith currently serves as Executive Vice President, Global Head R&D, and Chief Medical Officer of Jazz Pha
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415